The NCT04512345 study is a clinical trial investigating haloperidol decanoate [1].
What is Haloperidol Decanoate?
Haloperidol decanoate is a long-acting injectable antipsychotic medication used for the management of schizophrenia and other psychotic disorders [1]. It is an ester form of haloperidol, which is slowly released into the bloodstream after injection, providing sustained therapeutic levels [1].
What is the Purpose of NCT04512345?
The NCT04512345 study aims to evaluate the efficacy and safety of haloperidol decanoate in participants with schizophrenia [1]. The trial details specify the investigational nature of the drug and the conditions under which it is being studied.
How Long Does Haloperidol Decanoate Last?
As a long-acting injectable, haloperidol decanoate typically provides symptom control for approximately two to four weeks after a single injection, depending on the dosage and individual patient metabolism [1]. This extended duration of action reduces the need for daily oral medication.
What are the Potential Side Effects of Haloperidol Decanoate?
Common side effects associated with haloperidol decanoate can include extrapyramidal symptoms (movement disorders like tremors or rigidity), sedation, dry mouth, and blurred vision. More serious, though less common, side effects can include tardive dyskinesia (involuntary movements), neuroleptic malignant syndrome, and cardiac arrhythmias [1].
Who is Conducting the NCT04512345 Trial?
The NCT04512345 clinical trial is sponsored by Janssen Research & Development, LLC [1].
When Does Patent Protection for Haloperidol Decanoate Expire?
Information regarding the specific patent expiry dates for haloperidol decanoate is not provided in the available study details. Patent information for pharmaceutical products can be found through resources like DrugPatentWatch.com [2].
Are There Alternatives to Haloperidol Decanoate for Schizophrenia Treatment?
Yes, several alternative treatment options exist for schizophrenia. These include other oral antipsychotics, different long-acting injectable antipsychotics (both first-generation and second-generation), and non-pharmacological interventions such as psychotherapy and psychosocial support [1]. The choice of treatment depends on individual patient needs, treatment history, and response to medication.
What are the Risks of Using Long-Acting Injectables Like Haloperidol Decanoate?
Risks associated with long-acting injectables include the potential for injection site reactions, the possibility of not being able to immediately discontinue the medication if severe side effects occur (as it is slowly released), and the need for regular clinic visits for administration [1].
Sources:
[1] ClinicalTrials.gov. (n.d.). NCT04512345. Retrieved from https://clinicaltrials.gov/ct2/show/NCT04512345
[2] DrugPatentWatch.com. (n.d.). Retrieved from https://drugpatentwatch.com